» Articles » PMID: 24587625

Helicobacter Pylori and Gastric Cancer: Indian Enigma

Overview
Specialty Gastroenterology
Date 2014 Mar 4
PMID 24587625
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Helicobacter pylori (H. pylori) is a gram negative microaerophilic bacterium which resides in the mucous linings of the stomach. It has been implicated in the causation of various gastric disorders including gastric cancer. The geographical distribution and etiology of gastric cancer differ widely in different geographical regions and H. pylori, despite being labeled as a grade I carcinogen, has not been found to be associated with gastric cancer in many areas. Studies in Asian countries such as Thailand, India, Bangladesh, Pakistan, Iran, Saudi Arabian countries, Israel and Malaysia, have reported a high frequency of H. pylori infection co-existing with a low incidence of gastric cancer. In India, a difference in the prevalence of H. pylori infection and gastric cancer has been noted even in different regions of the country leading to a puzzle when attempting to find the causes of these variations. This puzzle of H. pylori distribution and gastric cancer epidemiology is known as the Indian enigma. In this review we have attempted to explain the Indian enigma using evidence from various Indian studies and from around the globe. This review covers aspects of epidemiology, the various biological strains present in different parts of the country and within individuals, the status of different H. pylori-related diseases and the molecular pathogenesis of the bacterium.

Citing Articles

Current paradigms in the management of refractory Helicobacter pylori infection.

Jearth V, Panigrahi M Indian J Gastroenterol. 2023; 42(6):766-779.

PMID: 37737326 DOI: 10.1007/s12664-023-01448-3.


Association of Helicobacter Pylori in Carcinoma Stomach at Maharaja Krishna Chandra Gajapat Medical College: A Prospective Study.

Behera A, Dash M, Soren D, Nayak K, Rath D, Behera S Cureus. 2022; 14(10):e30709.

PMID: 36439609 PMC: 9694525. DOI: 10.7759/cureus.30709.


" treatment guideline: An Indian perspective": Letter to the editor.

Swarnakar R, Yadav S World J Clin Cases. 2022; 10(29):10817-10819.

PMID: 36312482 PMC: 9602215. DOI: 10.12998/wjcc.v10.i29.10817.


Gastrointestinal microbiome and : Eradicate, leave it as it is, or take a personalized benefit-risk approach?.

Sitkin S, Lazebnik L, Avalueva E, Kononova S, Vakhitov T World J Gastroenterol. 2022; 28(7):766-774.

PMID: 35317277 PMC: 8891730. DOI: 10.3748/wjg.v28.i7.766.


Clinical Effect of Clarithromycin Combined with Tinidazole on Helicobacter pylori-Related Gastritis and Its Influence on COX-2 Expression.

He C, Kong F, Zhu X, Kong F, Zhao W, Liu Y Biomed Res Int. 2021; 2021:4171019.

PMID: 34888378 PMC: 8651390. DOI: 10.1155/2021/4171019.


References
1.
Kumar N, Mukhopadhyay A, Patra R, De R, Baddam R, Shaik S . Next-generation sequencing and de novo assembly, genome organization, and comparative genomic analyses of the genomes of two Helicobacter pylori isolates from duodenal ulcer patients in India. J Bacteriol. 2012; 194(21):5963-4. PMC: 3486096. DOI: 10.1128/JB.01371-12. View

2.
Singh V, Trikha B, Nain C, Singh K, Vaiphei K . Epidemiology of Helicobacter pylori and peptic ulcer in India. J Gastroenterol Hepatol. 2002; 17(6):659-65. DOI: 10.1046/j.1440-1746.2002.02746.x. View

3.
Tomb J, White O, Kerlavage A, Clayton R, Sutton G, Fleischmann R . The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature. 1997; 388(6642):539-47. DOI: 10.1038/41483. View

4.
Tiwari S, Manoj G, Sharma V, Sivaram G, Saikant R, Bardia A . Relevance of Helicobacter pylori genotypes in gastric pathology and its association with plasma malondialdehyde and nitric oxide levels. Inflammopharmacology. 2010; 18(2):59-64. DOI: 10.1007/s10787-010-0031-y. View

5.
Mathew A, Gangadharan P, Varghese C, Nair M . Diet and stomach cancer: a case-control study in South India. Eur J Cancer Prev. 2000; 9(2):89-97. DOI: 10.1097/00008469-200004000-00004. View